e765f894-131a-44f4-9060-4404b5a01001
A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy
Whole blood, small RNA expression profiles from a total of 334 stage IV NSCLC patients were analysed. This data was used to train models to predict overall survival following immunotherapy.
Whole blood, small RNA expression profiles from a total of 334 stage IV NSCLC patients were analysed. This data was used to train models to predict overall survival following immunotherapy.